CLINICAL_TRIALS
trial_result
· 2016-04-27
Clinical Trial Update: A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404) [Phase 1]
Summary
Phase I study evaluating the safety and immunogenicity of the TB vaccine candidate AERAS 404 (C-011-404) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aeras | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED